The new meta for cholesterol testing?

This is where things might start to get interesting in the next few years.

If you’ve ever had bloodwork through your GP or a private lab, there’s a 90% chance you’ve had a lipid panel. Total cholesterol, LDL, HDL, triglycerides

These are some markers your doctor looks at whether he decides whether to mention statins, and moves on.

And for decades this was common pratcice. Or at least, it was all we had until now.

But as the science begins to slowly evolve, particularly in the biohacking and longevity space — we’re beginning to see more in-depth testing emerge

The deeper we go down the rabbit hole, the more pigeon holes we create. More markers, more nuance, more opportunity to actually understand what’s happening inside your arteries instead of guessing from a few numbers on a page/document.

How testing has evolved

A standard lipid panel would usually gives you LDL, HDL, and triglycerides. The next level up adds ApoB and Lp(a) — more specific markers that start to assess the actual atherogenic particles, the ones contributing to plaque buildup downstream.